Cyclophosphamide independently enhances daratumumab-mediated killing of MM cells by altering the tumor microenvironment to promote macrophage recruitment, polarization to a professional-inflammatory phenotype, and directing ADCP.Furthermore, we also pay back excellent focus towards the tactics to scale back toxicity of triptolide, aiming to market